Home › NDC Lookup › RxCUI directory › RxCUI 1037234

Benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.... — RxCUI 1037234

RxNorm drug concept · Semantic clinical drug
RxCUI 1037234 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1037234
Official nameBenzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)262 prescriptions · 5 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methenamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • That's a great question. Methenamine isn't used to clear an active infection — it's used to prevent another one from taking hold. Once your other antibiotic has done that job, meth...
  • Why do I need to take methenamine if my infection is already gone?
  • Yes, it actually does. Methenamine only converts into its active antibacterial form in acidic urine. Foods and medications that make your urine more alkaline — less acidic — can re...
  • Does it matter what I eat or drink while I'm on this medication?
📖 Read our full Methenamine guide →

🕸️ Concept Web — How Benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Oral Tablet RxCUI 1037234

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 8

    The active substance itself — no strength, form, or brand attached yet.

    • Benzoate 70589
    • Hyoscyamine 153970
    • Methenamine 6832
    • Methylene blue 6878
    • Phenyl salicylate 36122
    • Benzoate / hyoscyamine / methenamine / methylene blue / phenyl salicylate 1008788
    • Benzoic acid 18989
    • Hyoscyamine sulfate 1225
  2. Brand names 3

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Hyophen 1037229
    • Prosed DS 1245487
    • Uribel Tabs 2670302
  3. Dose forms 21

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Benzoate / hyoscyamine / methenamine / methylene blue / phenyl salicylate Oral Tablet 967089
    • Benzoic acid / hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate Oral Tablet 2648127
    • Benzoate / hyoscyamine / methenamine / methylene blue / phenyl salicylate Oral Product 1151689
    • Benzoate / hyoscyamine / methenamine / methylene blue / phenyl salicylate Pill 1152005
    • Benzoic acid / hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate Oral Product 2663554
    • Benzoic acid / hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate Pill 2661160
    • Benzoate / hyoscyamine / methenamine / methylene blue / phenyl salicylate Oral Tablet [Hyophen] 1037231
    • Benzoate / hyoscyamine / methenamine / methylene blue / phenyl salicylate Oral Tablet [Prosed DS] 1245489
    • +13 more in this family
  4. Clinical & branded drugs 11

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 27 of 43 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Benzoic acid 9 MG SCDC · 346120
  • Hyoscyamine sulfate 0.12 MG SCDC · 1037233
  • Methenamine 81.6 MG SCDC · 340422
  • Methylene blue 10.8 MG SCDC · 384913
  • Phenyl salicylate 36.2 MG SCDC · 340423
  • Benzoate / hyoscyamine / methenamine / methylene blue / phenyl salicylate Oral Tablet SCDF · 967089
  • Benzoic acid / hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate Oral Tablet SCDFP · 2648127
  • Benzoate / hyoscyamine / methenamine / methylene blue / phenyl salicylate Oral Product SCDG · 1151689
  • Benzoate / hyoscyamine / methenamine / methylene blue / phenyl salicylate Pill SCDG · 1152005
  • Benzoic acid / hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate Oral Product SCDGP · 2663554

Brand-Name Concepts

  • Benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Oral Tablet [Uribel Tabs] SBD · 2670308
  • Benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Oral Tablet [Hyophen] SBD · 1037236
  • Benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Oral Tablet [Prosed DS] SBD · 1245492
  • Benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG [Hyophen] SBDC · 1037235
  • Benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG [Prosed DS] SBDC · 1245488
  • Benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG [Uribel Tabs] SBDC · 2670303
  • Benzoate / hyoscyamine / methenamine / methylene blue / phenyl salicylate Oral Tablet [Hyophen] SBDF · 1037231
  • Benzoate / hyoscyamine / methenamine / methylene blue / phenyl salicylate Oral Tablet [Prosed DS] SBDF · 1245489
  • Benzoate / hyoscyamine / methenamine / methylene blue / phenyl salicylate Oral Tablet [Uribel Tabs] SBDF · 2670306
  • Benzoic acid / hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate Oral Tablet [Hyophen] SBDFP · 2657769

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1037234 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00178-0745-01 100 TABLET, COATED in 1 BOTTLE (0178-0745-01) URIBEL TABS Mission Pharmacal Company 2023-11-07
Observed labelers: Mission Pharmacal Company (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.